| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 54910-48-4 | 3(S)-Oxidosqualene | C30H50O |
| 54910-51-9 | (2S,3R)-2-Decyl-3-(5-methylhexyl)oxirane | C19H38O |
| 54910-69-9 | 2,5-Anhydro-D-Altritol | C6H12O5 |
| 54910-89-3 | Fluoxetine | C17H18F3NO |
| 54911-32-9 | O-2-Amino-2,3-Dideoxy-alpha-D-Ribo-Hexopyranosyl-(1->4)-O-[O-alpha-D-Mannopyranosyl-(1->4)-O-2,6-Diamino-2,6-Dideoxy-beta-L-Idopyranosyl-(1->3)-beta-D-Ribofuranosyl-(1->5)]-2-Deoxy-D-Streptamine Sulfate (Salt) | C29H57N5O22S |
| 54911-85-2 | 4-(Tetrahydro-2H-Pyran-2-Yloxy)Butanal | C9H16O3 |
| 54912-87-7 | 1,1,1,7,7,7-Hexafluoro-2,6-Bis(Trifluoromethyl)-3-Heptene-2,6-Diol | C9H6F12O2 |
| 54913-26-7 | (3aS)-1,2,3a,4,4abeta,6,7,9,13bbeta,13cbeta-Decahydro-7beta-Hydroxy-9alpha-(Hydroxymethyl)-11-Methoxy-5,12-Dimethyl-4alpha,6alpha-Methano-5H-Benz[h]Oxazolo[3,2-a]Pyrazino[3,2,1-de][1,5]Naphthyridine-10,13-Dione | C21H25N3O5 |
| 54914-37-3 | 1,3,3-Trimethyl-N-(2-Methylpropylidene)-5-[(2-Methylpropylidene)Amino]Cyclohexanemethylamine | C18H34N2 |
| 54914-38-4 | N,N-Bis(2-Hydroxypropyl)Dodecanamide | C18H37NO3 |
| 54914-85-1 | 1,2-Bis(3-methylphenoxy)ethane | C16H18O2 |
| 54914-98-6 | Trisodium 7-Aminonaphthalene-1,3,6-Trisulphonate | C10H6NNa3O9S3 |
| 54915-31-0 | 3-Hydroxy-5-(phenylmethoxy)benzoic Acid Methyl Ester | C15H14O4 |
| 54915-62-7 | Ethyl 2-Furylcarbamate | C7H9NO3 |
| 54915-68-3 | 3,4-Dihydro-1(2H)-Quinolinecarboxylic Acid Ethyl Ester | C12H15NO2 |
| 54916-27-7 | 1-(4-(4-Bromophenoxy)Phenyl)Ethanone | C14H11BrO2 |
| 54916-28-8 | 4-Acetyl-4'-Methoxydiphenyl Ether | C15H14O3 |
| 54916-65-3 | 5-Chloro-2-methoxynicotinic acid | C7H6ClNO3 |
| 54916-66-4 | 5-Bromo-2-methoxynicotinic acid | C7H6BrNO3 |
| 54918-02-4 | (2S,3S,4R,5R)-5-(2,4-Diketopyrimidin-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-carboxamide | C9H11N3O6 |
| 54918-13-7 | [(2R,3S,5R)-2-Cyano-5-(5-Fluoro-2,4-Dioxo-Pyrimidin-1-Yl)Oxolan-3-Yl] Acetate | C11H10FN3O5 |
| 54919-49-2 | 3-Ethyl-2-Methyl-5-Phenyl-Benzooxazol-3-Ium Iodide | C16H16INO |
| 54920-74-0 | 2-(1-Methyl-1H-Benzimidazol-2-Yl)Acetamide | C10H11N3O |
| 54920-77-3 | 2,4-Dibromo-1,7-Naphthyridine | C8H4Br2N2 |
| 54920-82-0 | 1,7-Naphthyridin-2(1H)-One | C8H6N2O |
| 54920-83-1 | 2-Bromo-1,7-Naphthyridine | C8H5BrN2 |
| 54920-84-2 | 1,7-Naphthyridin-2-Amine | C8H7N3 |
| 54920-98-8 | 2-((2-Aminophenyl)thio)benzoic acid | C13H12NO2S |
| 54921-60-7 | 7-Oxo-11-dodecenoic acid | C12H20O3 |
| 54921-79-8 | 1,1'-(Phenylmethylene)Bis(2,4,6-Trimethoxybenzene) | C25H28O6 |
| 54921-80-1 | 1,1'-[(4-Nitrophenyl)Methylene]Bis(2,4,6-Trimethoxybenzene) | C25H27NO8 |
| 54923-31-8 | 3-Bromo-6-hydroxy-2-methylpyridine | C6H6BrNO |
| 54923-37-4 | [(4-Chlorophenyl)-Isoquinolin-1-Yl-Methyl] Benzoate | C23H16ClNO2 |
| 54924-33-3 | (4-Fluoro-Phenyl)-Piperidin-4-Yl-Methanol | C12H16FNO |
| 54924-46-8 | 1-[2-(2-Oxoimidazolidin-1-Yl)Ethyl]-3-Phenylurea | C12H16N4O2 |
| 54924-47-9 | 3-Aminotetrahydro-1,3-Oxazin-2-One | C4H8N2O2 |
| 54924-78-6 | 5-Bromo-2-Ethoxybenzamide | C9H10BrNO2 |
| 54925-33-6 | Cytidine cyclic-3',5'-monophosphate Sodium Salt | C9H12N3O7P |
| 54925-64-3 | 1-(tert-Butyldimethylsilyl)imidazole | C9H18N2Si |
| 54925-71-2 | 2'-O-tert-Butyldimethylsilyluridine | C15H26N2O6Si |
| 54925-87-0 | Lysyl-Phenylalanyl-Lysine | C21H35N5O4 |
| 54925-88-1 | H-Tyr-Lys-OH | C15H23N3O4 |
| 54927-77-4 | 3-Pentanone-D10 | |
| 54927-81-0 | (2S)-2-Amino-4-[(2R)-2-Amino-3-Hydroxy-3-Oxopropyl]Sulfinylbutanoic Acid | C7H14N2O5S |
| 54927-86-5 | [(1R,4R,4aS,8aS)-3,4a,8,8-Tetramethyl-7-Oxo-4-[(2-Oxochromen-7-Yl)Oxymethyl]-4,5,6,8alpha-Tetrahydro-1H-Naphthalen-1-Yl] Acetate | C26H30O6 |
| 54928-05-1 | Phytolaccagenic acid | C31H48O6 |
| 54928-24-4 | 5-Bromo-6-Methoxy-4-Pyrimidinamine | C5H6BrN3O |
| 54929-35-0 | 2,3,5-Trifluoro-4-Pyridinol | C5H2F3NO |
| 54929-36-1 | 5-Chloro-2,3-Difluoro-4-Pyridinol | C5H2ClF2NO |
| 54929-38-3 | 3,5-Dibromo-2-Fluoro-4-Hydroxypyridine | C5H2Br2FNO |